| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.394 | 10.427 | 9.008 | 8.210 | 4.746 | 12.767 | 8.967 | 970 | 0 |
| Total Income - EUR | - | 9.394 | 10.427 | 9.008 | 8.210 | 4.746 | 12.767 | 8.967 | 970 | 0 |
| Total Expenses - EUR | - | 1.326 | 1.746 | 2.099 | 1.154 | 1.155 | 2.898 | 1.752 | 598 | 0 |
| Gross Profit/Loss - EUR | - | 8.067 | 8.681 | 6.909 | 7.056 | 3.591 | 9.869 | 7.214 | 372 | 0 |
| Net Profit/Loss - EUR | - | 7.785 | 8.368 | 6.638 | 6.804 | 3.457 | 9.486 | 6.945 | 313 | 0 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tonmag 99 Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 514 | 364 | 219 | 79 | 0 | 0 | 0 | 0 |
| Current Assets | - | 9.497 | 10.719 | 12.020 | 12.856 | 10.807 | 16.427 | 16.594 | 614 | 611 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.195 | 631 | 579 | 980 | 730 | 405 | 1.132 | 249 | 21 |
| Cash | - | 8.302 | 10.088 | 11.441 | 11.875 | 10.077 | 16.021 | 15.462 | 366 | 590 |
| Shareholders Funds | - | 7.830 | 8.421 | 10.392 | 11.937 | 9.999 | 13.906 | 6.994 | 614 | 611 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.667 | 2.813 | 1.992 | 1.138 | 888 | 2.520 | 9.600 | 0 | 0 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Tonmag 99 Med Srl